Liver -

Steatohepatitis

This article was last reviewed and updated on May 31, 2018
by Stephanie Reid, MD FRCPC
 

Quick facts:

  • Steatohepatitis is liver disease where droplets of fat are found inside the cells normally found in the liver.

  • The liver cells also show signs of injury and cells from the immune system are often found nearby. 

  • The causes of fatty liver disease include alcohol use, central obesity, diabetes, certain medications, diet, and genetic diseases (such as Wilson’s disease).

Learn more

The liver is an organ found in the right upper part of your abdominal cavity. It is responsible for removing toxins, processing medications, and producing substances such as bile that are essential for breaking down and using food.

 

The liver can be affected by diseases other than tumours. These are broadly referred to as ‘medical liver disease’. In these diseases, there is damage to specific cell types or areas of the liver. The liver contains multiple types of cells which make up its structure and contribute to function. The main type of cell in the liver is called a hepatocyte. The liver also has biliary cells which line the inside of long channels called bile ducts, and endothelial cells which line the inside of blood vessels. There are also a variety of background of cells and materials that support and hold all of these other parts of the liver together. In medical liver disease, any of these structures may be affected or damaged.

 

Steatohepatitis is one type of disease in a category of medical liver disease called ‘fatty liver disease’. In fatty liver disease, there are fat droplets inside the hepatocytes. The causes of fatty liver disease include alcohol use, central obesity, diabetes, certain medications, diet, and genetic diseases (such as Wilson’s disease).

There are two major types of steatohepatitis: non-alcoholic and alcoholic. Alcoholic steatohepatitis occurs due to alcohol use. Non-alcoholic steatohepatitis can be caused by a variety of conditions including central obesity, diabetes, and dietary factors. When looking at a liver biopsy under the microscope, it is not possible to tell the difference between alcoholic and non-alcoholic steatohepatitis reliably, and often the distinction needs to be made by other doctors in your healthcare team after considering both your history, symptoms, and pathological results.

 

Steatohepatitis can present in a variety of ways. Some patients have no symptoms and the disease is discovered incidentally when a radiological image (a CT scan or ultrasound) of the abdomen is performed. It may also be discovered when a blood test shows elevated liver enzymes. Patients with steatohepatitis may also experience abdominal pain or a serious medical condition called ‘liver failure’. In all of these situations, your doctor may order a liver biopsy to determine if steatohepatitis is present.

 

A diagnosis of steatohepatitis requires a liver biopsy.  Your pathologist will look for four major microscopic features to determine the presence of and severity of steatohepatitis.

 

1. Steatosis

Steatosis is the term used to describe the presence of fat droplets within the hepatocytes. Steatosis can be a diagnosis on its own, or it can be a part of steatohepatitis. In steatosis, the hepatocytes contain clear areas of fat droplets when viewed under a microscope.

 

Pathologists use a scale to describe the amount of fat in a liver with steatosis. The scale is based on the percentage of liver cells that contain fat droplets:

 

The scale used by most pathologists includes:

 

  • Mild - fat droplets are seen within less than  33% of the hepatocytes in the biopsy

  • Moderate - fat droplets are seen within 33 - 66 % of hepatocytes in the biopsy

  • Severe - fat droplets are seen within greater than 66 % of hepatocytes in the biopsy.

 

2. Ballooning hepatocytes

Ballooning is a word pathologists use to describe damaged or dying hepatocytes. They are called ‘ballooning’ because the hepatocyte swells to several times its normal size and the body of the cell becomes clear.

 

Ballooning hepatocytes must be present in order to make a diagnosis of steatohepatitis. The amount of ballooning hepatocytes present will be described as mild, moderate, or severe.

 

3. Lobular or portal inflammation.

The liver is made up of three main compartments:

 

  1. The lobule which contains the hepatocytes

  2. The portal tract which contains a vein, an artery, and a bile duct

  3. The central vein which brings blood into the liver

 

Inflammatory cells can enter any of these areas and prolonged inflammation can damage the liver. If inflammatory cells are seen in your tissue, your pathologist will describe their location and the types of inflammatory cells present.  The amount of inflammation will also be described on a scale of mild, moderate, or severe.

 

Lobular inflammation is commonly seen in steatohepatitis.

 

4. Fibrosis

Fibrosis is a type of scar tissue that forms in the liver after damage. Because steatohepatitis damages the liver, there is a risk of developing fibrosis.

 

Most pathology reports comment on the amount of fibrosis and will assign it a ‘stage’. The stage is dependent on multiple factors including extent of initial injury, the length of time injury was occurring, and which parts of the liver were damaged. Too much fibrosis disrupts the architecture of the liver and prevents it from functioning properly.

 

There are several different classifications systems used to stage fibrosis but all of them include the type and amount of fibrosis seen. Cirrhosis is the last stage of fibrosis and it is characterized by large fibrous bands that form nodules in the liver. These nodules prevent the liver from carrying out its normal functions and may lead to a medical condition called ‘liver failure’.

 

Adequacy

The liver is divided into ‘zones’ and at the center of each zone is a structure called a ‘portal tract’. Portal tracts are important because they contain blood vessels and channels that move other substances such as bile in and out of the liver.

When examining a liver biopsy, your pathologist must first determine if the sample contains the minimum amount of portal tracts  required to make an accurate diagnosis. The adequacy of the biopsy may be reported simply as “yes” or “no”, or the number of portal tracts seen may be stated.

 

Fragmentation

The condition of the liver biopsy when viewed under the microscope is usually described. If the liver biopsy is brittle and has broken apart this will be described, as it may be a clue to specific liver conditions.

 

Mallory bodies

Mallory bodies form as a result of damage to hepatocytes. When viewed under the microscope, they look like dense pink material inside of the cells.

Mallory bodies are often found in steatohepatitis and will be described in your report if seen.

 

Bile Ducts

The liver produces a substance called bile which is used to remove toxins from the body and digest food. The bile produced in the liver drains through channels called bile ducts into the small bowel. Each portal tract contains one bile duct.

 

There is a category of medical liver disease which effect the bile ducts. For this reason, your pathologist will examine the bile ducts to see if the normal amount of bile ducts are present and if any of the bile ducts are damaged.

Cholestasis

Cholestasis is a word pathologists use to describe bile trapped in the liver. Trapped bile is important because it can cause liver injury. If cholestasis is seen, your pathologist will describe its location within the liver and the amount of trapped bile will be described as mild, moderate, or severe.

Iron

Iron can build up within the liver as a result of abnormal breakdown of iron, increased iron in the body (such as after multiple blood transfusions), or when the liver is not functioning properly (as in liver cirrhosis). This excess iron can be seen within the hepatocytes or within immune cells called macrophages. If iron is present in your tissue, your pathologist will report its location and severity.

  • Facebook
  • Twitter

Copyright 2017 MyPathologyReport.ca

For more information about this site, contact us at info@mypathologyreport.ca.

Disclaimer: The articles on MyPathologyReport are intended for general informational purposes only and they do not address individual circumstances. The articles on this site are not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the MyPathologyReport site. The articles on MyPathologyReport.ca are intended for use within Canada by residents of Canada only.

Droits d'auteur 2017 MyPathologyReport.ca
Pour plus d'informations sur ce site, contactez-nous à info@mypathologyreport.ca.
Clause de non-responsabilité: Les articles sur MyPathologyReport ne sont destinés qu’à des fins d'information et ne tiennent pas compte des circonstances individuelles. Les articles sur ce site ne remplacent pas les avis médicaux professionnels, diagnostics ou traitements et ne doivent pas être pris en compte pour la prise de décisions concernant votre santé. Ne négligez jamais les conseils d'un professionnel de la santé à cause de quelque chose que vous avez lu sur le site de MyPathologyReport. Les articles sur MyPathologyReport.ca sont destinés à être utilisés au Canada, par les résidents du Canada uniquement.